← Back to Bills
HR 620118th CongressFailed / ExpiredHouse

Alzheimer’s Accountability and Investment Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Dec 5, 2025
Latest Action Date
May 31, 2024

Latest Action

Placed on the Union Calendar, Calendar No. 442.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Alzheimer's Accountability and Investment Act (H.R. 620) is a legislative proposal introduced in the 118th Congress aimed at addressing Alzheimer's disease through increased accountability and investment. The bill's specific provisions and detailed text are not available, but it is categorized under the health policy area and was placed on the Union Calendar. The bill ultimately failed or expired without becoming law.

Bottom Line

H.R. 620 sought to enhance efforts related to Alzheimer's disease but did not advance to enactment during the 118th Congress.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill is focused on Alzheimer's disease, indicating an emphasis on health-related interventions or funding.
  • It was introduced in the House of Representatives and placed on the Union Calendar, suggesting it was scheduled for consideration.
  • The bill did not pass and is currently listed as failed or expired.
Who Benefits?

["Individuals affected by Alzheimer's disease and their families", "Health agencies involved in Alzheimer's research and care", 'Healthcare providers and organizations specializing in neurodegenerative diseases']

Potential Concerns

['Lack of publicly available full bill text limits understanding of specific implementation mechanisms and funding sources', 'Unclear oversight and accountability provisions due to missing detailed legislative language', 'Potential costs and resource allocation impacts cannot be assessed without detailed bill content']

Political Context

The bill was introduced during the 118th Congress and placed on the Union Calendar, indicating it was scheduled for floor consideration in the House. However, it did not advance to passage and is recorded as failed or expired. The absence of a summary and full text in the public record limits detailed legislative context.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

["Potential increased federal investment in Alzheimer's research and care if enacted", 'Possible influence on related health policy and funding priorities', "Enhanced focus on accountability in managing Alzheimer's disease programs"]

GovScope Watchdog Notes

The absence of a full bill text and official summary limits comprehensive analysis and public understanding. Transparency in legislative documentation is essential for effective oversight and informed stakeholder engagement. Monitoring future similar bills for complete disclosure is recommended.

Passage Likelihood: LowConfidence: 70%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready